Access to essential medicines for sexual and reproductive health care: the role of the pharmaceutical industry and international regulation

References

• World Health Organization. Reproductive health strategy to accelerate progress towards the attainment of international development goals and targets. 2004; WHO: Geneva.
   Google Scholar
• Affordable drugs for so-called diseases of poverty. PROCAARE Healthnet. 13 September 2007.
   Google Scholar
• UN Development Programme. Goal 8: a global partnership for development. New York, UNDP. At: <www.undp.org/mdg/goal8.shtml. >. Accessed 10 August, 2011.
   Google Scholar
• United Nations MDG Gap Task Force. Millennium Development Goal 8: the global partnership for development at a critical juncture. 2010; UN MDG Gap Task Force Report: New York.
   Google Scholar
• United Nations. World Contraceptive Use 2009. 2009; UN: New York.
   Google Scholar
• China Research Intelligence. Research Report on China's Condom Market, 2009. At: <www.prlog.org/10180042-research-report-on-chinas-condom-market-2009.html. >. Accessed 9 August 2011.
   Google Scholar
• S Singh, JE Darroch, LS Ashford. Adding It Up: The costs and benefits of investing in family planning and maternal and newborn health. 2009; Guttmacher Institute, UN Population Fund: New York.
   Google Scholar
• PATH World Health Organization United Nations Population Fund. Essential Medicines for Reproductive Health: Guiding principles for their inclusion on national medicines lists. 2006; PATH: Seattle. At: <www.who.int/reproductivehealth/publications/general/a91388/en/index.html. >. Accessed 9 August 2011.
   Google Scholar
• A Furedi. New emergency contraceptive method ellaOne® – is it worth the price?. Reproductive Health Matters. 17(34): 2009; 187–188.
   Web of Science ®Google Scholar
• S Sinding, J Bongaarts. Response to letter from Petroni S. International Perspectives on Sexual and Reproductive Health. 35(3): 2009. At: <www.guttmacher.org/pubs/journals/3515309.html. >.
   Google Scholar
• JK Drake, LH Thi Thanh, C Suraratdecha. Stakeholder perceptions of a total market approach to family planning in Viet Nam. Reproductive Health Matters. 18(36): 2010; 46–55.
   Web of Science ®Google Scholar
• TKS Ravindran. Privatisation in reproductive health services in Pakistan: three case studies. Reproductive Health Matters. 18(36): 2010; 13–24.
   Web of Science ®Google Scholar
• World Health Organization. Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008. 2011; WHO: Geneva.
   Google Scholar
• WHO UNICEF UNFPA World Bank. Trends in maternal mortality: 1990 to 2008. 2010; World Health Organization: Geneva.
   Google Scholar
• I Shah, E Ahman. Unsafe abortion in 2008: global and regional levels and trends. Reproductive Health Matters. 18(36): 2010; 90–101.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global burden of disease. Geneva, 2004. Update. At: <www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html. >. Accessed 9 August 2011.
   Google Scholar
• World Health Organization. The Interagency List of Essential Medicines for Reproductive Health. 2006; WHO: Geneva.
   Google Scholar
• World Health Organization. Service availability mapping. At: <www.who.int/healthinfo/systems/samintro/en/index.html. >. Accessed 9 August, 2011.
   Google Scholar
• World Health Organization. Prevalence and incidence of selected sexually transmitted infections: Chlamydia, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. 2011; WHO: Geneva.
   Google Scholar
• World Health Organization. Global strategy for the prevention and control of sexually transmitted infections: 2006–2015. 2006; WHO: Geneva.
   Google Scholar
• Joint United Nations Programme on HIV/AIDS. UNAIDS report on the global AIDS epidemic 2010. 2010; UNAIDS: Geneva, 16.
   Google Scholar
• World Health Organization. Mother-to-child transmission of HIV. At: <www.who.int/hiv/topics/mtct/en/index.html. >. Accessed 9 August 2011.
   Google Scholar
• World Health Organization. Guidelines on HIV and infant feeding 2010. 2010; WHO: Geneva.
   Google Scholar
• United Nations. International Covenant on Economic, Social and Cultural Rights. UN General Assembly, 1966; and General Comment No.14: the right to the highest attainable standard of health. New York: United Nations, Committee on Economic, Social and Cultural Rights, 2000.
   Google Scholar
• World Health Organization. Essential medicines programme. At: <www.who.int/medicines/areas/policy/en/index.html. >. Accessed 9 August 2011.
   Google Scholar
• Datamonitor. Commercial Insight: hormonal contraceptives – look beyond oral contraception for a competitive edge. October 2009. At: <www.researchandmarkets.com/research/f10fda/commercial_insight. >. Accessed 9 August, 2011.
   Google Scholar
• Shahani S. Cardiovascular medicine: diagnostics, drugs and devices. BCC Research. Report ID:HLC041B. November 2007.
   Google Scholar
• See, for example, “Age critique – âge dynamique”, a brochure published by Wyeth for women and distributed throughout Switzerland in pharmacies (Undated). It specifically states that “HRT does not increase risk of breast cancer; it might even diminish it.” (p.39)
   Google Scholar
• N Krieger, I Löwy, R Aronowitz. Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical and advocacy perspectives. Journal of Epidemiology and Community Health. 59: 2005; 740–748.
   PubMed Web of Science ®Google Scholar
• Farquhar CM, Marjoribanks J, Lethaby A, et al, and the Cochrane HT Study Group. Long term hormone therapy for perimenopausal and postmenopausal women (Review). 2007.
   Google Scholar
• S Shahani. Hormone replacement therapies and other hormone therapies: global markets. BCC ResearchReport ID:PHM055A. September 2008. At: <www.bccresearch.com/report/PHM055A.html. >. Accessed 9 August 2011.
   Google Scholar
• World Health Organization. Global Burden of Disease, 2004 update. 2008; WHO: Geneva.
   Google Scholar
• J Ferlay, F Bray, P Pisani. Globocan 2002: Cancer incidence, mortality and prevalence worldwide. 2004; IARC Press: Lyon. Cited in: Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reproductive Health Matters 2008;16(32):104–12.
   Google Scholar
• International Agency for Research on Cancer Working Group on Cervical Cancer Screening. Summary Chapter. M Hakama, AB Miller, NE Day. Screening for Cancer of the Uterine Cervix. 1986; IARC: Lyon, 133–142.
   Google Scholar
• C Banura, FM Mirembe, AR Katahoire. Epidemiology of HPV genotypes in Uganda and the role of the current preventive vaccines: a systematic review. Infectious Agents and Cancer. 6(1): 2011; 11.
   Web of Science ®Google Scholar
• T Harris, RD Burke, JM Palefsky. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 293: 2005; 1471–1476.
   PubMed Web of Science ®Google Scholar
• HW Chesson, DU Ekwueme, M Saraiva. The cost-effectiveness of male HPV vaccination in the United States. Vaccines. 2011; August 1. E-pub. (abstract only).
   Google Scholar
• CA Dietz, CR Nyberg. Genital, oral and anal human papillomavirus infection in men who have sex with men. Journal of American Osteopathic Association. 111(3 Suppl.2): 2011; S19–S25. (abstract only).
   Google Scholar
• S Margolis. HPV Vaccine controversy continues. Yahoo Health, 21 March 2007. At: <http://health.yahoo.net/search?q1=vaccine+controversy. >. Accessed 9 August 2011.
   Google Scholar
• SM Rothman, DJ Rothman. Marketing HPV vaccine: implications for adolescent health and medical professionalism. JAMA. 302(7): 2009; 781–786. doi: 10.1001/jama.2009.1179.
   PubMed Web of Science ®Google Scholar
• K Outterson. Will HPV vaccines prevent cervical cancers among poor women of color?: global health policy at the intersection of human rights and intellectual property law. American Journal of Law & Medicine. 35: 2009; 247–252.
   PubMed Web of Science ®Google Scholar
• B Roose-Snyder, MK Doyle. The global health licensing program: a new model for humanitarian licensing at the university level. American Journal of Law and Medicine. 35(2/3): 2009; 281–309.
   Web of Science ®Google Scholar
• R Bird. Developing country nations and compulsory licensing: maximizing access to essential medicines while minimising investment side effects. Journal of Law, Medicine & Ethics. Summer: 2009; 209–221.
   Google Scholar
• Bhardwaj K. Access to medicines and treatment – a reality check. Reported in: Repoliticizing sexual and reproductive health and rights: report of a global meeting, Langkawi, Malaysia, 3–6 August 2010. London: Reproductive Health Matters and Asian-Pacific Resource and Research Centre for Women, 2011.
   Google Scholar
• P Yu. Access to medicines, BRICS alliance and collective action. American Journal of Law and Medicine. 34: 2008; 345–394.
   PubMed Web of Science ®Google Scholar
• Intellectual Property Watch. Drug company reacts to Thai license: government ready to talk. 16 February 2007. At: <www.ip-watch.org/weblog/2007/02/16/drug-company-upset-by-newest-thai-license-government-open-to-dialogue. >. Accessed 9 August 2011.
   Google Scholar
• JP Love. Recent examples of the use of compulsory licenses on patents. 2007; Knowledge Ecology International: London. At: <http://keionline.org/content/view/41/1. >. Accessed 9 August 2011.
   Google Scholar
• G Mudur. India's proposed pact with Europe may choke its generic drug exports, health rights activists fear. BMJ. 342: 2011; d1480.
   Google Scholar
• J Zaracostas. Trade talks on patent protection violate right to health, allege advocacy groups. BMJ. 342: 2011; d1993.
   Google Scholar
• Report to the General Assembly of the United Nations Special Rapporteur on the right to the highest attainable standard of health. A/63/263. 2008; UN: New York.
   Google Scholar
• K Beer, F Armand. Assessment of India's locally manufactured contraceptive product supply. 2006; Private Sector Partnerships-One Project, Abt Associates Inc: Bethesda, MD.
   Google Scholar
• Merck & Co, Inc. Rwanda, Merck and QIAGEN launch Africa's first comprehensive cervical cancer prevention program incorporating both HPV vaccination and HPV testing. At: <www.merck.com/newsroom/news-release-archive/vaccine-news/2011_0425.html. >. Accessed 15 August 2011.
   Google Scholar
• Annual report 2006, Ingelheim. Boehringer Ingelheim GmbH, 2007.
   Google Scholar
• Merck & Co, Inc. Looking ahead: 2009–2010 corporate responsibility review. Whitehouse Station, NJ, 2010.
   Google Scholar
• HIV/AIDS: Gilead first to join Medicines Patent Pool. IRIN PlusNews. Nairobi, 12 July 2011.
   Google Scholar
• World Health Organization. Medicines: counterfeit medicines. Fact Sheet No.275, January 2010. At: <www.who.int/mediacentre/factsheets/fs275/en/index.html. >. Accessed 9 August 2011.
   Google Scholar
• CS Park. Legal aspects of defining “counterfeit medicines”. A discussion paper. 2009; World Health Organization: New Delhi.
   Google Scholar
• M Mulumba. Anti-counterfeiting legislation in East Africa: a new assault against TRIPS flexibilities for access to medicine?. 2010; Centre for Health, Human Rights and Development: Kampala.
   Google Scholar
• Boseley S. Scandal of Africa's missing medicines. Guardian Weekly. 2 October 2009. p.42–43.
   Google Scholar
• International Partnership for Microbicides. Proof of concept established for microbicides. At: <www.ipmglobal.org/publications-media/proof-concept-established-microbicides. >. Accessed 9 August 2011.
   Google Scholar
• A Peters, W Jansen, F van Driel. The female condom: the international denial of a strong potential. Reproductive Health Matters. 18(35): 2010; 119–128.
   PubMed Web of Science ®Google Scholar
• PATH. New partnership supports reproductive health options for women. 2001. At: <www.path.org/news/an110214-womans-condom.php. >. Accessed 9 August 2011.
   Google Scholar
• A Banerjee, A Hollis, T Pogge. The Health Impact Fund: incentives for improving access to medicines. Lancet. 375: 2010; 166–169.
   PubMed Web of Science ®Google Scholar
• TT Htay. Making pregnancy safer in Myanmar: introducing misoprostol to prevent post-partum haemorrhage as part of active management of the third stage of labour. Reproductive Health Matters. 15(30): 2007; 214–215.
   Google Scholar
• E 't Hoen, J Berger, A Calmy. Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of International AIDS Society. 14: 2011; 15.
   Web of Science ®Google Scholar